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ABSTRACT                
Background and aim: Personality functioning is predictive of drug misuse and relapse, yet 
little is known about the role of personality in engagement with the treatment process. This 
study aimed to estimate the extent to which broad and facet level characteristic adaptations 
contribute to or hinder treatment engagement, while controlling for psychosocial indicators. 
Design: Multi-site cross-sectional survey. Setting: Inpatient treatment units covering 80% of 
residential treatment entries in Greece. Participants: 338 service users, 287 (84.9%) male, 51 
(15.1%) female, average age 33.4 years. Measurements: Expressions of personality 
functioning (characteristic adaptations) were assessed using the Severity Indices of Personality 
Problems (SIPP-118). Treatment engagement was measured using the Client Evaluation of Self 
and Treatment, inpatient version (CEST). Findings:  Dysfunctional levels of Relational 
Capacities predicted Counselling Rapport (β= 1.50, 95%CI= 0.36 to 2.69, p=. 013), Treatment 
Participation (β=2.09, 95%CI= 1.15 to 3.11, p< .001) and Treatment Satisfaction (β= 1.65, 
95%CI=.073 to 2.57, p< .001). Counselling Rapport was also predicted by dysfunctional levels 
in Self-Control (β= 1.78, 95%CI=.89 to 2.67, p< .001), Self-Reflective Functioning at the facet 
level (β= 2.24, 95%CI= 1.01 to 3.46, p< .001) and Aggression Regulation (β= 1.43, 95%CI= 
0.43 to 2.42, p= .005). Dysfunctional levels on Social Concordance (β= -1.90, 95%CI= -2.87 
to - .94, p= .001), Emotional Regulation (β= 1.90, 95%CI= .87 to 2.92, p< .001) and Intimacy 
(β=2.04, 95%CI= 1.31 to 3.05, p< .001) were significant predictors of Treatment Participation. 
Treatment Readiness and Desire for Help predicted treatment engagement. Conclusions: In 
people attending substance use treatment services, maladaptive interpersonal patterns and 
relational intimacy, emotional dysregulation and impulse control may be associated with low 
levels of Counselling Rapport and Treatment Participation. Low frustration tolerance and 
aggressive impulses also appeared to predict low participation. 
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After years of separation of personality research from treatment research, a considerable 
literature has now grown around the themes of dimensional evaluation of personality 
functioning [1,2,3,4,] and personality matched-interventions [5,6]. In the addictions field, there 
is some evidence suggestive of a relationship between personality and poor outcomes, 
including treatment attrition [7,8] and relapse [9,10,11] but there has been surprisingly little 
investigation of whether personality influences a client’s ability to actively engage with the 
treatment process. This is important because clients’ engagement in therapy, often 
conceptualised as active participation, good counselling rapport and satisfaction with the 
ongoing process, has been consistently associated with increased tenure in treatment, reduction 
of drug use and improved post treatment outcomes [12,13,14]. In contrast, lack of treatment 
engagement has been associated with early drop out and relapse [15,16].  
One of the most consistent predictors of lack of engagement, treatment drop out and relapse is 
clients’ comorbidity, in particular when substance use disorder co-exists with personality 
disorder [17,18]. However, diagnostic indicators to rule out personality disorder 
symptomatology are based on the behavioural expression and extremity of certain maladaptive 
traits that mimic personality pathology [19,20] and increase the risk of over-diagnosis of 
personality disorder among those with substance use disorders. Consequently, overlapping 
symptomatology as well as lack of clarity and clear distinction between and within diagnostic 
categories have prompted several prominent researchers to suggest alternatives [21,22].  
Current research is evolving towards the recognition that a number of personality traits and 
personality dysfunction commonly observed in drug users do not necessarily reflect diagnosis 
of personality disorder pathology [4]. This has led to significant improvements of the 
categorical-based diagnostic procedures, by including progressive methods of dimensional 
assessment [23] disentangling personality traits from disorders and discriminating the 
conceptual differentiation of stable dispositions from context sensitive characteristic 
adaptations [24].  
Contemporary diagnosis according to the new Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5) involves the assessment of Personality Functioning Scale (PFS), a hybrid 
model that simultaneously uses the traditional categorical approach of DSM-IV, along with a 
dimensional approach. This provides a more comprehensive assessment of pathological 
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personality trait domains as well as a “Level of Personality Functioning-Scale”, as an overall 
measure of the severity of personality dysfunction [24]. This approach is also a significant step 
towards improving the clinical utility of the diagnostic manual as it provides a detailed 
description of individuals’ personality profile including personality traits and characteristic 
adaptations. These characteristic adaptations refer to the dynamic organization of personality 
such as affect tolerance and impulse regulation, self and other representations, identity, coping 
strategies, and acquired skills. Individuals’ characteristic adaptations profile could provide a 
more in-depth understanding of personality in treatment. As Joe et al. (1999) suggested, 
therapeutic involvement requires a certain degree of adaptation to the social context [26]. Any 
variation of treatment responses may result from the interaction between an individual’s 
characteristic adaptations and the capacity of the contextual environment, including therapists, 
to work with those who exhibit difficulties in adapting to, for example, social norms and 
programme expectations.  
Current evidence in non-substance misuse settings suggests that personality functioning is 
malleable towards more adaptive levels in response to treatment [27], that the levels of 
adaptation predict differential response to treatment  [28], and that more maladaptive levels are 
associated with worse treatment response [29] and increased likelihood of attrition [30,31]. 
Therefore, the identification of personality functioning that may activate dysfunctional 
behavioural patterns during treatment is of significant clinical importance. Delineating the role 
of personality functioning within treatment process could contribute to the identification of 
individual attrition vulnerabilities so that they can adequately addressed early on, prevent 
premature termination and enhance clients’ engagement. Practically, this would imply that 
despite personality traits’ stability, treatment interventions could moderate the degree of 
dysfunctional behavioural phenotypes by targeting the partially context-sensitive characteristic 
adaptations.  The aims of this study were 1) to investigate the effects of broad and facet level 
characteristic adaptations on indicators of early treatment engagement– namely, Counselling 
rapport, Treatment Participation and Treatment satisfaction; and 2) to elucidate and explain 
differences in the levels of engagement according to personality dimensions, while controlling 
for age, gender, drug use, psychosocial characteristics, motivation and treatment modality. We 
hypothesised that more dysfunctional personality adaptations would be negatively related to 







This paper describes part of a larger Greek treatment effectiveness study examining the therapy 
process using a quantitative multi-site individual follow-up design in naturalistic treatment 
settings. This paper focuses on the early inpatient phase to explore the relationship between 
service users’ characteristic adaptations and their early treatment engagement.  
Treatment services  
For this part of the study, five inpatient treatment units were recruited from the two major 
publicly funded treatment organizations (one providing therapeutic community treatment, one 
psychosocial rehabilitation) that provide free of charge, psychosocial care for alcohol and 
substance misuse and have the largest number of individuals seeking therapy, jointly covering 
more than 80% of the treatment demand in Greece [32]. The five units (two therapeutic 
communities and three psychosocial rehabilitation units) cover different geographical regions, 
two were in Athens, one in Piraeus, one in Salamina and one in Thessaloniki. The two treatment 
organizations are similar in terms of both therapeutic interventions, protocols and 
organizational structure. Both have 6-12 week outpatient phases (in practice mostly 9 weeks) 
followed by 6-9 month inpatient phase, with similar procedures to progress from one phase to 
the next. Treatment in both modalities consists of a mix of individual counselling and group 
therapy, although there are some differences in staff backgrounds, e.g. the involvement of 
former service user staff in therapeutic community treatment.  
Ethics 
The study received ethics approval from the University of Sheffield. Since data collection 
involved clients undergoing substance misuse treatment, the study also obtained approval by 
the Institutional Review Board of the organisations involved in the study. 
Recruitment procedure  
We used a cohort sampling approach: All individuals who were admitted to the inpatient 
treatment phase in the above-mentioned units for a 36 months period (sampling period was 
determined by study timescales) were contacted individually by the researcher (FP) and invited 
to participate. The eligibility criteria were: 1) at least 18 years old, 2) used illicit drugs during 
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the past 90 days, 3) able to read and speak Greek fluently, 4) no current or previous experience 
of psychotic symptoms and 5) no serious developmental disabilities or cognitive disturbances. 
Eligibility was determined through pre-screen data and information supplied by the treatment 
providers and clinical records. Those who expressed interest and met the inclusion criteria 
received the related documents including study information sheet and consent form. Only 
participants who read and signed the consent form were included in the research. The final 
sample from the inpatient phase is 338 participants, 204 from the therapeutic communities and 
134 from the psychosocial rehabilitation units. The participation rate was 98% of eligible 
clients.  
Measures and administration 
Clinical and demographic information  
Clinical data were routinely collected by the treatment services during the service’s initial 
intake procedures and included Treatment Demand Indicator [33] and Addiction Severity Index 
[34,35] scores. These measures provided information regarding service users’ demographic 
(sex, age, marital status, level of education, current employment status) and substance use 
information (primary and secondary drug of choice, frequency of drug use and route of drug 
administration).  
Personality and treatment engagement  
Personality, treatment engagement and the remaining covariates were assessed between the 2nd 
and 4th week after admission to the inpatient phase of treatment. Pilot assessments were 
conducted in both organizations in order to examine and fine-tune the administration process. 
The final administration procedure involved the completion of all questionnaires on the same 
day. The approximate time required for completion of the assessment battery was 45 – 60 
minutes.  
Personality. The Severity Indices of Personality Problems [SIPP-118, 36] is a 118-item 
dimensional self-report measure to assess the core components of personality functioning (i.e. 
characteristic adaptations). The measure comprises 16 facets clustered into five higher-order 
“broad” domains named Social Concordance, the ability to value someone’s identity, withhold 
aggressive impulses towards others and to work together with others; Relational functioning, 
the capacities for interpersonal communication and relational intimacy; Self-control, the 
capacity to tolerate, use and control one’s own emotions and impulses; Responsibility, the 
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capacity to set realistic goals and to achieve them in line with the expectations you have 
generated in others; and Identity Integration, the ability to see oneself and one’s own life as 
stable, integrated and purposive. High scores in the facets, and on the broad domains, indicate 
better adaptive functioning. Broad level characteristic adaptations are the weighted sum of the 
facet level scores, with weights provided in the SIPP technical report [37]. The SIPP has 
demonstrated good validity in several countries on clinical and non-clinical populations 
[38,39]. The SIPP-118 and the CEST (below) were professionally translated into Greek for this 
study and internal reliability for the facet level scales were good, ranging from α=.74 to α=.96 
in this study.  
Treatment engagement. This study used the treatment process model of the Texas Christian 
University [14] to conceptualize clients’ engagement. Therefore, we used the Client Evaluation 
of Self and Treatment, inpatient version [CEST, 40]. The CEST conceptualizes Treatment 
Engagement as multidimensional construct that encompasses behavioural (Treatment 
Participation; 12 items), cognitive (Treatment Satisfaction; 7 items), and interpersonal 
(Counselling Rapport; 14 items) components, with self-completion items scored on 5-point 
Likert scales. These key treatment process indicators have consistently received empirical 
support as significant predictors of increased tenure and improved post treatment outcomes 
[12,13,14,15]. Scores for each of the subscales are obtained by summing responses to the set 
of items (after reversing scores on reflected items by subtracting the item response from “6”), 
dividing the sum by number of items included (yielding an average) and multiplying by 10 in 
order to rescale final scores to range from 10 to 50 (e.g., an average response of 2.6 for a scale 
becomes a score of “26”). Published reliability and validity information for the CEST is 
available [7]. 
Other covariates: Four motivational scales of CEST were used evaluating the levels of 
Problem Recognition, Desire for Help and Treatment Readiness including an index for 
Pressures for Treatment. The psychological domains of the CEST were used to assess 
Depression and Anxiety, and social functioning indicators were comprised of scales for 







Data analysis was conducted using the statistical software SPSS20. Descriptive analysis was 
performed to present the distribution of the sample’s demographic and key study variables. 
Quality control involved double entry of a random ten percent of cases, checking for missing 
values, outliers and unexpected values, and scatterplots (to identify any unexpected 
associations between variables and bivariate outliers). Coding that was unexpected or missing 
was cross-checked with the treatment units prior to analysis. In order to test assumptions for 
the second part of the analyses, all predictors and criterion variables were tested for normality 
using kurtosis, skewness, Kolmogorov-Smirnov tests and the normal Q-Q Plot.  
A series of regression analyses examined the impact of the characteristic adaptations (5 broad 
characteristics Self-Control, Relational Capacities, Social Concordance, Responsibility, 
Identity Integration and their 16 facet-level subcomponents) on treatment engagement 
(repeating the analyses described below for Counselling Rapport, Treatment Participation and 
Treatment Satisfaction). Initially, bivariate regression analyses were used to assess which 
personality variables predicted each engagement indicator independently. Then we estimated 
a series of two-stage multiple regression models, predicting each of the three treatment 
engagement indicators in turn. Covariates (age, gender, marital status, education level, drug 
use, injecting status, legal problems, the CEST treatment motivation, anxiety and depression 
scales and treatment site) were included in the first step for each model. In the second step, a 
forward stepwise procedure was applied for either the five broad characteristic adaptations or 
the 16 facet-level characteristic adaptations, applying a probability of p = 0.10 for entry and 
removal for each of the variables considered.  Out of the 338 participants, 315 were included 
in these analyses, while 23 (6.8%) were excluded due to missing values in core items. The R2 
for the initial model and the R2 change (denoted as ΔR2) for the final model are reported below 
each Table.  As the analysis plan was not pre-registered on a publicly available platform, results 








Sample characteristics  
Sample. The sample consisted of n=338 service users in the inpatient phase of substance abuse 
treatment. The average age was 33 years, and the majority were males, single and unemployed 
(see Table 1). Overall, 193 (57.1 %) successfully completed the treatment programme, while 
145 (42.9 %) dropped out prior to completion.  
(Table 1 about here) 
 
 
Broad and facet level characteristic adaptations as predictors of Treatment engagement 
The demographic, substance use, emotional wellbeing, motivational and treatment site control 
variables together explained 36.7% of the variance in Counselling Rapport, 20.7% of the 
variance in Treatment Participation and 29.4% of the variance in Treatment Satisfaction. The 
motivational variables Desire for Help and Treatment Readiness were consistently related with 
treatment engagement indicators. In contrast, neither demographics, substance use 
characteristics nor treatment site were associated with treatment engagement.  
After entry of the five higher-order personality dimensions at step two, the total variance 
explained by the models was 45% of the variance in Counselling Rapport (+9%), 35% of the 
variance in Treatment Participation (+14.6%), and 32% of the variance in Treatment 
Satisfaction (+2.8%).  
Counselling Rapport: In the final multiple stepwise regression model including the five broad 
domains and all covariates (Table 2a), Self-Control and Relational Capacities were significant 
positive predictors of Counselling Rapport. At the facet level (Table 2b), Self-Reflective 
Functioning, Aggression Regulation and Enduring Relationships were positively associated 
with better counselling relationships.  
Treatment Participation: The broad domains (Table 3a) Social Concordance, Relational 
Capacities, Self-Control and Responsibility were significant predictors, indicating that service 
users who had more dysfunctional levels on these domains had lower levels of Treatment 
Participation. At the facet level (Table 3b), higher levels of Emotional Regulation, Intimacy, 
Trustworthiness and Respect were associated with more Treatment Participation.  
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Treatment Satisfaction: Of the broad level adaptations (Table 4a), only Relational Capacities 
was positively related with Treatment Satisfaction in the adjusted model. At the facet level 
(Table 4b), two relational concepts, Intimacy and Cooperation, explained additional variance 
in Treatment Satisfaction after adjusting for the effects of the other covariates, suggesting that 
Treatment Satisfaction is influenced by the clients’ ability to form close, positive relationships 
with others.  
 




More dysfunctional personality characteristic adaptations were strongly related to poorer 
Treatment Participation and Counselling Rapport and moderately related to Treatment 
Satisfaction. The present study’s findings lend support to the notion that characteristic 
adaptation help to understand the association of personality with a client’s treatment 
experience. It is the first study to set out to discover whether personality functioning as 
measured through characteristic adaptations might assist in the identification of potential 
obstacles to treatment engagement in substance misuse treatment. The evidence provided in 
this study is broadly consistent with, and extends, previous studies in diverse clinical 
populations which found that personality functioning was associated with differential 
responses to treatment [28], with maladaptive levels predicting poorer treatment response [29] 
and non-engagement [30,31]. High levels of emotional dysregulation had also previously been 
found to be associated with non-compliance, denial and behavioural disengagement [41]. Our 
study, adopting TCU’s multivariate conceptualization including interpersonal, behavioural and 
cognitive components of treatment engagement, found that individuals with dysfunctional 
levels in Self-Control or Relational Capacities were less likely to report good therapeutic 
relationships (Counselling Rapport). Similarly, the behavioural component of engagement 
(Treatment Participation) was most strongly associated with Social Concordance, Relational 
Capacities and Self-Control, and the cognitive component of treatment engagement (Treatment 
Satisfaction) was also influenced by the capacities for interpersonal communication and 
relational intimacy (Relational Capacities).  
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The analysis at the facet level adaptations representing intrapersonal (e.g., identity integration), 
interpersonal characteristics (e.g., intimacy), adaptations indicating disturbed prosocial 
behaviour (e.g., aggression regulation), as well as control or regulating behaviour (e.g., 
responsibility; effortful control) provided a framework for more meaningful interpretations. 
For instance, while the broad domains Identity Integration and Social Concordance were not 
statistically significant predictors of Counselling Rapport, the examination at the facet level 
showed that Self-Reflective Functioning from the Identity Integration domain and Aggression 
Regulation from the Social Concordance domain were strong predictors of Counselling 
Rapport. Likewise, Emotional Regulation, a facet of the Self-Control domain, along with 
Intimacy, a facet of the Relational Capacities domain, were the strongest significant predictors 
of Treatment Participation. This is consistent with the latest revision of the DSM-5 [42], where 
the concepts of Identity and Relational Functioning are seen as core markers of personality 
pathology and important predictors of dysfunction [43]. Surprisingly, identity and interpersonal 
functioning have not often been used to predict treatment outcomes in clinical or research 
settings [44]. 
In contrast to the traditional categorical system, contemporary dimensional based assessments 
integrate personality traits and the levels of personality functioning to advance clinical utility 
and capture the core impairments in personality pathology that would be able to predict 
possible therapeutic alliance problems in therapy [45]. Our study lend support to this 
hypothesis, since higher maladaptive scores on Self-Reflective Functioning significantly 
predicted low Counselling Rapport. Individuals who had dysfunctional scores on the capacity 
to understand the possible meanings of and causal connections between internal and external 
experiences were significantly less likely to develop a trusting counselling relationship with 
their therapist.  
Ruptures in the alliance may be conceptualized as a normal condition in the treatment process 
that partially reflects clients’ dysfunctional interpersonal patterns [46]. However, in treatment, 
failure to identify and address them early on may lead to re-enactments, further ruptures of 
alliance and premature termination. Several authors reported that clients with prior 
dysfunctional relationships are more likely to have difficulties in establishing and maintaining 
therapeutic relationships [47] and drop out from treatment [48]. Supporting previous findings, 
results in this study indicated that Enduring Relationship, a facet of Relational domain, was 
also a significant predictor of Counselling Rapport.  
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Finally, literature indicates that clients’ Hostility, coldness and social avoidance have been 
found to predict poor therapeutic alliance [49,50]. In support of this, service users with high 
dysfunctional levels on Aggression Regulation and Hostility were significantly less likely to 
develop Counselling Rapport in this study. The findings extend our knowledge that 
dysfunctional levels on Self-Reflective Functioning, Aggression Regulation and Enduring 
Relationship significantly impaired the development of Counselling Rapport. Finally, 
individuals with higher maladaptive scores on Responsible industry, “the capacity to set 
realistic goals, and to achieve these through effective and responsible constructive actions”, 
and Respect, “the capacity to value someone’s individual needs and personal identity”, were 
significantly less likely to participate actively in the treatment process. Some variables are 
consistent with suppressor effects. In univariable analyses Anxiety was negatively associated 
with outcomes Counselling Rapport, Treatment Participation and Treatment Satisfaction. 
However, in the final six distinct multivariable models Anxiety demonstrated positive 
association with the outcome. Social Concordance and Respect also showed suppressor effects 
with the outcome Treatment Participation. 
There are clinical implications of these findings. For example, dysfunctional levels on 
Emotional regulation and Intimacy may alert counsellors that a client is at heightened risk of 
not being able to fully engage. Likewise, dysfunctional levels on Self-reflective functioning, 
Aggression regulation and Enduring relationships could provide an early warning sign for 
significant difficulties in building trusting therapeutic relationships. Thus, providers could 
anticipate that individuals might require further clinical attention and support on these issues 
and employ staff with appropriate skills to deliver strategically targeted interventions to ensure 
that individuals’ needs are met. There are various recent examples of the clinical utility of 
dimensional conceptualizations of personality functioning for development of individualized 
treatment plans [21, 25, 51]. Given its ability to disentangle current personality functioning 
from stable traits and personality disorders, mapping characteristic adaptations can allow 
clinicians to develop subgroup norms with similar characteristics, identify which type of clients 
respond better to what type of treatment and subsequently facilitate the development of person-
oriented clinical formulations. It has been suggested, for example, that work with clients with 
emotion dysregulation may include a focus on developing emotion regulating strategies, such 
as attentional redeployment, reappraisal, mindful tolerance and problem solving [52]. In 
contrast, those with disinhibition problems might benefit from contingency management, 
motivational mentoring and instrumental reinforcement approaches [27]. 
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Strengths and limitations  
This study explored the relationship between service users’ personality and their treatment 
engagement in naturalistic treatment settings. Most studies have focused only on major 
personality traits. The current study is novel in that it examined the relationship between broad 
and facet level characteristic adaptations and different components of treatment engagement, 
in much greater detail and in a way that is consistent with current understandings of the likely 
interplay between personality expressions on the one hand, and treatment processes and 
outcomes on the other. 
Limitations of the study include that the sample was drawn from inpatient treatment settings 
only, which may limit the ability to generalize findings across treatment settings and types of 
treatment. Despite recruiting a large proportion of the eligible sample over a significant period 
of time, the sample was still not very large and some of the confidence intervals are wide. Also, 
Greek inpatient services mainly treat heroin users. Further work is needed to replicate the 
findings with larger samples and in treatment populations with different substance misuse 
profiles. The study was cross-sectional and considered personality and treatment engagement 
in the early inpatient phase, rather than assessing changing characteristic adaptations and 
engagement levels over time. Several factors that may influence treatment engagement were 
not assessed, such as personal circumstances of service users other than those captured by the 
services’ intake assessments or conflicts with practitioners, and thus need to be seen as potential 
confounders. Behavioural observation measures are sometimes seen as more appropriate for 
capturing personality predispositions than self-reports. However, as the focus was to identify 
the phenotypic expression of personality, self-report measures provides data that is more 
relevant to this particular study, that is, data on individuals’ own perception of their behavioural 
tendencies [33].  
Conclusions and recommendations for future research 
Given the significant role of treatment engagement in driving positive treatment outcomes, it 
is hoped that this study can provide the basis for the development of personalized clinical 
strategies. A next step is to test whether dysfunctional personality patterns are associated with 
long-term treatment outcomes. If so, it would be worth investigating whether counsellors can 
use knowledge of personality functioning to individualise treatment plans to meet specific 
needs of their clients (e.g. focused therapeutic work such as insight interpersonal oriented 
interventions for identity and relational capacities, while cognitive behavioural for affect 
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regulation and behavioural disinhibition), and whether personality-aware treatment adaptations 
improve treatment retention and substance misuse outcomes.  To take this work further, clinical 
investigations should employ similar empirically driven assessment procedures and conceptual 
dimensional-based frameworks. Future studies could also incorporate qualitative methodology 
to explore how the partially context-sensitive characteristic adaptations relate to clients’ 
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Table 1. Demographic and personality characteristics 
Demographic and drug use variables n % Mean SD 
     
Age  338 33.37   
Gender Male 287 84.9   
 Female 51 15.1   
Marital Status   Single 160 55.4   
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   Married 27 9.3   
   Divorced 26 9.0   
   Living together 51 17.6   
   Unknown 25 8.7   
Educational level  Graduate primary school 31 11.7   
   Graduate secondary school 194 73.5   
   Graduate University 17 6.6   
   Unknown 22 8.3   
Drug of Choice   Benzodiazepines 8 3   
   Cocaine 13 5.3   
   Heroin 201 76.5   
   Cannabis 18 6.8   
   Unknown 19 7.4   
Injected   Yes 103 39   
   No 161 61   
Legal problems Yes 125 47   
 No 139 53   
Psychology Depression   26.99 7.77 
   Anxiety   30.54 7.83 
Motivation   Treatment needs   37.98 7.61 
 Desire for help   43.21 4.27 
 Treatment readiness   39.73 5.72 
   Pressures for treatment   30.67 6.36 
Engagement Levels by treatment type       
Counselling Rapport TC 204   38.50 6.13 
PR 132  41.78 5.41 
   Treatment Participation TC 204  39.43 5.35 
PR 132  41.01 4.46 
Treatment Satisfaction TC 204  37.82 5.77 
PR 132  40.46 5.51 
  Characteristic adaptations broad level     
Self-Control 338  4.21 .91 
 Emotion Regulation   2.36 .61 
 Effortful Control   2.14 .53 
Identity Integration 338  3.97 .64 
 Self-Respect   2.81 .59 
 Stable self-image   2.63 .59 
 Self-reflective functioning   2.51 .56 
 Enjoyment   2.54 .54 
 Purposefulness   2.85 .49 
Responsibility 338  4.12 .75 
 Responsible industry   2.65 .58 
 Trustworthiness   2.77 .52 
Relational capacities 338  4.22 .67 
 Intimacy   2.78 .51 
 Enduring relationships   2.73 .53 
 Feeling recognized   2.75 .53 
Social concordance 338  5.27 .77 
 Aggression regulation   2.90 .71 
 Frustration tolerance   2.41 .47 
 Cooperation   2.90 .51 
 Respect   2.87 .46 
  Retention Rate by treatment unit Completed Dropout 
   N % N % 
  Nostos 53 44.5 66 55.5 
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Therapeutic Community Ithaki 43 12.7 43 50 
 
Psychosocial Rehabilitation 
Patision 48 72.7 18 27.3 
Exarhieia 32 69.6 14 30.4 
Aristidou 17 81 4 19 
Total  193 57.1 145 42.9 
Treatment Engagement by Unit CR TP TS 
Nostos M SD M       SD M        SD 
Ithaki 39.06 5.47 39.46 5.12 38.21 5.31 
Patision 37.76 6.87 39.41 5.67 37.29 6.33 
Exarheia 41.82 5.33 41.25 4.64 40.13 5.34 
Aristidou 43.80 4.03 40.68 4.82 40.43 5.36 
 40.80 5.95 40.95 3.14 41.63 4.38 
  CR: Counselling rapport; TP: Treatment participation; TS: Treatment satisfaction 
Table 2a: Counselling Rapport predicted by broad level characteristic adaptation       
   Unadjusted   Adjusted model 
(stepwise entry 
 
 Covariates   CI   CI  
  β Lower Upper P β Lower Upper P 
Demographic variables           
 Age .130 .023 .237 .018 .002 -.096 .099 .975 
 Gender .281 -1.56 2.13 .765 .437 -2.23     3.10 .747 
 Marital Status .387 -.065 .838 .093 ---    
 Educational level -.382 -.778 .014 .059 ---    
Drug use and legal problems        
 Drug of Choice -.254 -.653 .145 .211 ---    
 Injected  -.042 -1.17 1.08 .942 ---    
 Legal problems  3.02 1.75 4.28 .000 1.80 .425 3.12 .010 
Psychological wellbeing         
 Depression -.184 -.264 -.103 .000 -.068 -.175 .039 .212 
 Anxiety -.112 -.194 -.030 .008 .105 -.007     .218  .067 
Motivation         
 Treatment needs -.081 -.184 .021 .118 ---    
 Desire for help .369 .221 .516 .000 2.87 .126 .448 .001 
 Treatment readiness .577 .481 .673 .000 3.31     .204 .459 .000 
 Pressures for treatment -.025 -.111 .060 .560 ---    
Treatment Modality         
 Unit TC Ith^     -1.33 -3.35     .682 .194 
 Unit PR Ex^     -.666 -2.55 1.22 .487 
 Unit PR Ar^     -.442 -4.03 3.14 .808 
 Unit TC No^     -.895    -2.66    .870 .319 
Characteristic adaptations broad domains (IV)      
 Self-Control 2.74 2.03 3.40 .000 1.78 .899 2.67 .000 
 Identity Integration 3.32 2.35 4.28 .000 NS    
 Responsibility 2.68 1.86 3.50 .000 NS    
 Relational Capacities 3.27 2.33 4.20 .000 1.50 .326 2.69 .013 
 Social Concordance 3.07 2.27 3.87 .000 NS    
Key: IV=independent variable, ---- = variables not entered in multiple model; NS=variables were 
entered in multiple model but not selected by stepwise method. Notes: Sample size for multiple analyses 
N=315. 5 Treatment units transformed into Dummy variables and the coefficients are estimated to the 
reference. Stepwise Forward entry criterion p < 0.05. Stepwise model F (10,315) = 26.625, p< 0.01, 









 Table 2b: Counselling Rapport predicted by facet level characteristic adaptation       
   Unadjusted   Adjusted model 
(stepwise entry) 
   CI   CI  
  β Lower Upper P β Lower Upper P 
 Covariates         
Demographic variables        
 Age .130 .023 .237  .018   .010 -.086 .106   .841 
 Gender .281 -.1.56 2.13  .765 .179    -2.43 2.79      .893 
 Marital Status .387 -.065 .838  .093 ----    
 Educational level -.382 -.778 .014  .059 ---    
Drug use and legal problems        
 Drug of choice -.254 -.653 .145  .211 ---    
 Injected -.042 -1.17 1.08  .992 ---    
 Legal problems 3.02 1.75 4.28  .000   1.73     .383   3.08 .012 
Psychological wellbeing        
 Depression -.184 -.264 -.103  .000   -.096 -.201  .009     .074 
 Anxiety -.112 -.194 -.030  .008   .121   0.10 .232  0.33 
Motivation                 
 Treatment needs -.081 -.184 .021 .118   ---    
 Desire for help .369 .221 .516 .000  .264 .107 .421    .001 
 Treatment 
readiness 
.577 .481 .673 . 000  .319 .191 .446    .000 
 Pressures for 
treatment 
-.025 -.111 .060 .560  ---    
Treatment 
Modality 
           
 Unit TC Ith^     -1.60 -3.58 .382 .113 
 Unit PR Ex^     -.516 -2.38 1.35 .586 
 Unit PR Ar^     -.018 -3.55 3.51 .992 
 Unit TC No^     -1.14 -2.90     .623 .204 
Characteristic adaptations facet levels 
(IV) 
      
Self-Control         
 Emotion 
Regulation 
3.56 2.47 4.64  .000 NS    
 Effortful Control 3.67  2.51 4.82  .000 NS    
Identity Integration        
 Self-Respect 2.37 1.28 3.47  .000 NS    
 Stable self-image 3.44 2.36 4.51  .000     
 Self - reflective 
functioning 
   3.81     2.70    4.92 .000  2.24   1.01  3.46  .000 
 Enjoyment 3.56 2.40 4.72  .000     
 Purposefulness 3.04 1.72 4.38  .000     
Responsibility         
 Responsible 
industry 
3.44 2.35 4.54  .000     
 Trustworthiness 3.51 2.28 4.73  .000     
Relational capacities        
 Intimacy 3.73       2.50 4.96  .000     
 Enduring 
relationships 
   3.56 2.37     4.75 .000   1.49 .143 2.84 .030 
 Feeling 
recognized 
3.58       2.38 4.78  .000 NS    
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Key: IV=independent variable, ---- = variables not entered in multiple model; NS=variables were 
entered in multiple model but not selected by stepwise method. Notes: Sample size for multiple analyses 
N=314. ^ 5 Treatment units transformed into Dummy variables and the coefficients are estimated to the 
reference. Stepwise Forward entry criterion p < 0.05. Stepwise model F (14,31) = 17.418, p < 0.01. Full 
model R2= 0.479. Model without characteristic adaptation variables R2 = 0.367. ΔR2= .112  (p< .001). 
 
  
Social concordance    NS    
 Aggression 
regulation 
   3.15     2.28     4.03  .000     1.43   .438 2.42 .005 
 Frustration 
tolerance 
4.45    3.11 5.78  .000 NS    
 Cooperation 3.61    2.37 4.84  .000 NS    
 Respect 3.76    2.37 5.16  .000 NS    
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Table 3a: Treatment participation predicted by broad domains characteristic adaptations  
   
       Unadjusted 
      Adjusted model 
      (stepwise entry) 
   CI   CI  
  β Lower Upper P β Lower Upper P 
Demographic variables 
Age .095 .005    .184 .039 -.007 -.084 .070 .856 
Gender .135  -1.41 1.68 .864 2.30 .568 4.02 .009 
 Marital Status .092 -.282 .465 .628 NS   
 Educational level    -.343 -.675 -.012 .042 NS   
Drug use and legal problems 
 Drug of Choice -.059 -.394 .276 .728 ---   
 Injected .122 -.824 1.07 .799 ---   
Legal problems 1.62 .537 2.70 .003 ---    
Psychological wellbeing 
Depression -.145 -.212 -.077 .000 -.043 -.125 0.038 .297 
Anxiety  -.098 -.167 -.029 .005 .045 -0.03 0.126 .277 
Motivation 
Treatment needs  .016 -.069 .102 .708 ---    
Desire for help .338    .215    .461 .000 .223    .106 .340 .000 
Treatment readiness .338 .302 .474 .000 .207    .109 .304 .000 
  Pressures for treatment   -.052 -.124 .019 .151 ---   
  Treatment Modality         
  Unit TC Ith^     -1.08 -2.57 0.40 .151 
  Unit PR Ex^     -0.31 -1.90 1.27 .686 
  Unit PR Ar^     -3.13 -5.78 0.48 .391 
  Unit TC No^     -.817 -2.19 0.55 .244 
Characteristic adaptations 
Self-Control  1.98 1.39 2.57 .000 1.38 .513 2.25 .002 
  Identity Integration       2.55 1.75 3.35 .000 NS   
Responsibility .240 1.73 3.06 .000 .940 .123 1.76 .024 
Relational capacities .295 2.19 3.70 .000 2.09 1.15 3.113 .000 
Social concordance 1.59   .892 2.28 .000  -1.90  -2.87 -.941 .000 
Key: IV=independent variable, ---- = variables not entered in multiple model; NS=variables were 
entered in multiple model but not selected by stepwise method. Notes: Sample size for multiple 
analyses N=315. 5 Treatment units transformed into Dummy variables and the coefficients are 
estimated to the reference. Stepwise Forward entry criterion p < 0.05. Stepwise model F (14,314) 
=11.694, p < 0.00. Full model R2= 0.353. Model without characteristic adaptation variables R2 = 







Table 3b: Treatment participation predicted by facet level characteristic adaptations 
   Unadjusted   Adjusted model 
(stepwise entry) 
              CI   CI  
  β Lower Upper P β Lower Upper P 
 Covariates         
Demographic variables        
 Age .095 .005    .184 .039 -.008 -.084     .069 .844 
 Gender .135  -1.41 1.68 .864 2.73 -.995 4.46 .002 
 Marital Status .092 -.282 .465 .628 ---    
 Educational level -.343 -.675 -.012 .042 NS    
Drug use and legal problems        
 Drug of Choice -.059 -.394 .276 .728 ---    
 Injected -.122 -.824 1.07 .799 ---    
 Legal problems 1.62 .537 2.70 .003 ---    
Psychological wellbeing        
 Depression -.145 -.212 -.077 .000 -.059 -.139 .021 .150 
 Anxiety -.098 -.167 -.029 .005 .061   -.020       .141           .138 
Motivation                 
 Treatment needs  .016 -.069 .102 .708 ---    
 Desire for help .338    .215    .461 .000 .204 .088 .321 .001 
 Treatment readiness .338 .302 .474 .000 .194 .098     .291 .000 
 Pressures for treatment -.052 -.124 .019 .151 NS    
Treatment modality         
 Unit TC Ith^     -1.17  -2.65 .317 .123 
 Unit PR Ex^     -.365 -1.96 1.23 .653 
 Unit PR Ar^      -3.67 -6.41    -1.12 .006 
 Unit TC No^       -.733 -2.10     .639 .294 
Characteristic adaptations facet levels (IV)    
Self-Control         
 Emotion Regulation 2.96 2.07 3.85 .000 1.90    .872 2.92 .000 
 Effortful Control 2.31 1.34 3.28  .000 NS    
Identity Integration        
 Self-Respect 1.97 1.08 2.87   .000 NS    
 Stable self-image 2.60 1.71 3.49 .000 NS    
 Self - reflective 
functioning 
 2.83 1.91 3.76 .000 NS    . 
 Enjoyment 2.57 1.61 3.53   .000 NS    
 Purposefulness 2.63 1.55 3.72 .000 NS    
Responsibility     .    
 Responsible industry 3.11 2.22 4.00  .000 1.26 .309 2.21 .010 
 Trustworthiness  3.34 2.35 4.33  .000 NS    
Relational capacities        
 Intimacy 3.71 2.73 4.69  .000 2.04 1.31 3.05 .000 
 Enduring relationships 3.18 2.22 4.14  .000 .129    
 Feeling recognized 2.72 1.74 3.71 .000 NS    
Social concordance         
 Aggression regulation 1.60 .851 2.36 .000 NS    
 Frustration tolerance 3.15 2.04 4.26 .000 NS    
 Cooperation 2.53 1.50 3.55 .000 NS    
 Respect  1.37 1.85 2.55 .024 -1.65 -2.81 -.495 .005 
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Key: IV=independent variable, ---- = variables not entered in multiple model; NS=variables were 
entered in multiple model but not selected by stepwise method. Notes: Sample size for multiple 
analyses N=314. 5 Treatment units transformed into Dummy variables and the coefficients are 
estimated to the reference. Stepwise Forward entry criterion p< 0.05. Stepwise model F (14, 314) = 
11.762, p < .001. Full model R2= 0.354. Model without characteristic adaptation variables R2 = 0.207. 













  CI   CI  
 β Lower Upper P β Lower Upper P 
Demographic variables 
Age   .073    -.028 .174 .154 -.019 -.107 .069 .671 
Gender  -.065 -1.80 1.67 .941 -.207 -2.16 1.74 .835 
Marital Status    .079  -.339 .497 .710 NS   
Educational level   -.283  -.663   .097 .144 NS   
Drug use and legal problems 
Drug of Choice .106 -.277 .489 .585 ---   
Injected .643 -.433 1.72 .240 ---   
Legal problems 2.62 1.43     3.82 .000 ---    
Psychological wellbeing 
Depression -.168 -.243 -.092 .000 -.057 -.151 .038 .237 
Anxiety  -.091 -.168 -.013 .022 .057 -.035 .149 .222 
Motivation 
Treatment needs -.100 -.195 -.004 .041 ---    
Desire for help .381   .243 .518 .000 .200 .066 .334 .004 
Treatment readiness .495 .402 .588 .000 .348 .239 .457 .000 
  Pressures for treatment   -.002    -.083 .078 .953 ---   
  Treatment Modality             
 Unit TC Ith^     -1.25 -2.97 .465 .153 
 Unit PR Ex^     .422 -1.42 2.26 .652 
 Unit PR Ar^     .813 -2.34 3.86 .600 
 Unit TC No^     -.664 -2.34 .909 .407 
Characteristic adaptations 
Self-Control    1.70 1.02 2.38 .000 NS    
  Identity Integration     2.36 1.44 3.28 .000 NS   
Responsibility 1.86 1.07 2.65 .000 NS    
Relational capacities 2.65 1.78 3.53 .000 1.65 .735 2.57 .000 
Social concordance   2.05 1.28 2.82- .000 NS    
Key: IV=independent variable, ^ = Forced into the model ---- = variables not entered in multiple model; 
NS=variables were entered in multiple model but not selected by stepwise method. Notes: Sample size 
for multiple analyses N=314. 5 Treatment units transformed into Dummy variables and the coefficients 
are estimated to the reference. Stepwise Forward entry criterion p< 0.05. Stepwise model F (11, 314) = 
13.082, p < .000. Full model R2= 0.322 Model without characteristic adaptation variables R2 = 0.294. 









Table 4b: Treatment Satisfaction predicted by facet level characteristic adaptations  
 Unadjusted  Adjusted model 
(stepwise entry) 
  CI   CI  
 β Lower Upper P β Lower Upper P 
Demographic variables 
 Age ^   .073    -.028 .174 .154 -.018 -.106 .069 .680 
Gender^  -.065 -1.80 1.67 .941 -.137 -2.07 1.80 .889 
  Marital Status    .079  -.339 .497 .710 ---   
  Educational level  -.283  -.663   .097 .144 ---   
Drug use and legal problems 
  Drug of Choice .106 -.277 .489 .585 ---   
  Injected  .643 -.433 1.71 .240 ---   
Legal problems  2.62 1.43      3.82 .000        ---    
Psychological wellbeing 
Depression -.168 -.243 -.092 .000 -.069 -.161 .023 .141 
  Anxiety  -.091 -.168 -.013 .022 .077   -.016       .169    .106 
Motivation 
   Treatment needs  -.100 -.195 -.004 .041 ---   
 Desire for help .381   .243 .518 .000 .203    .070 .337 .003 
 Treatment readiness .495 .402 .588 .000 .334    .225 .444 .000 
 Pressures for treatment -.002        -.083     .078        .953 NS   
Treatment Modality            
Unit TC Ith^     -1.23 -2.94 .473 .156 
Unit PR Ex^     .335 -1.49 2.16 .718 
Unit PR Ar^     .520 -2.51 3.55 .735 
Unit TC No^     -.512  -2.08 1.05 .520 
Characteristic adaptations facet levels 
Self-Control 
Emotion Regulation  2.59 1.57 3.61 .000 NS    
  Effortful Control  1.92 .816 3.03 .001 NS   
Identity Integration 
  Self-Respect  1.56 .525 2.59 .003 NS   
  Stable self-image 1.74 .703 2.77 .000 NS   
Self - reflective 
functioning  
2.10 1.03 3.17 .001 NS    
  Enjoyment  2.93 1.82 4.03 .000 NS   
  Purposefulness 2.65 1.42 3.88 .000 NS   
Responsibility 
  Responsible industry  2.49 1.45 3.54 .000    
Trustworthiness  2.65 1.49 3.81 .000 NS    
Relational capacities 
Intimacy  3.53 2.39 4.67 .000 1.40    .178 2.63 .025 
Enduring relationships 2.78 1.66 3.90 .000 NS    
  Feeling recognized 2.48 1.34 3.62 .000 NS     
Social concordance 
Aggression regulation 1.56 .703 2.42 .000 NS    
  Frustration tolerance 3.25 1.97 4.52 .000 NS   
Cooperation 3.28 2.14 4.41 .000 1.54    .258 2.82 .019 
Respect 2.28 .948 3.61 .001 NS    
Key: IV=independent variable, ̂  = Forced into the model, ---- = variables not entered in multiple model; 
NS=variables were entered in multiple model but not selected by stepwise method. Notes: Sample size 
for multiple analyses N=314. 5 Treatment units transformed into Dummy variables and the coefficients 
are estimated to the reference. Stepwise Forward entry criterion p< 0.05. Stepwise model F (12, 314) = 
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12.620, p<.001. Full model R2= 0.334 Model without characteristic adaptation variables R2 = 0.294. 
ΔR2 = .040 (p< .001). 
 
